关注
Bastien Castagner
Bastien Castagner
在 mcgill.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Biomedical applications of bisphosphonates
EV Giger, B Castagner, JC Leroux
Journal of Controlled Release 167 (2), 175-188, 2013
2182013
Synthetically defined glycoprotein vaccines: current status and future directions
R Adamo, A Nilo, B Castagner, O Boutureira, F Berti, GJL Bernardes
Chemical science 4 (8), 2995-3008, 2013
1802013
Streamlined access to conjugation-ready glycans by automated synthesis
L Kröck, D Esposito, B Castagner, CC Wang, P Bindschädler, ...
Chemical Science 3 (5), 1617-1622, 2012
1682012
Automated synthesis of the tumor-associated carbohydrate antigens Gb-3 and Globo-H: incorporation of α-galactosidic linkages
DB Werz, B Castagner, PH Seeberger
Journal of the American Chemical Society 129 (10), 2770-2771, 2007
1672007
Gene delivery with bisphosphonate-stabilized calcium phosphate nanoparticles
EV Giger, J Puigmartí-Luis, R Schlatter, B Castagner, PS Dittrich, ...
Journal of Controlled Release 150 (1), 87-93, 2011
1422011
Activatable cell penetrating peptide–peptide nucleic acid conjugate via reduction of azobenzene PEG chains
SH Lee, E Moroz, B Castagner, JC Leroux
Journal of the American Chemical Society 136 (37), 12868-12871, 2014
1252014
A natural polyphenol exerts antitumor activity and circumvents anti–PD-1 resistance through effects on the gut microbiota
M Messaoudene, R Pidgeon, C Richard, M Ponce, K Diop, M Benlaifaoui, ...
Cancer Discovery 12 (4), 1070-1087, 2022
1132022
Well-defined multivalent ligands for hepatocytes targeting via asialoglycoprotein receptor
X Huang, JC Leroux, B Castagner
Bioconjugate chemistry 28 (2), 283-295, 2017
1112017
Is there a future for cell-penetrating peptides in oligonucleotide delivery?
SH Lee, B Castagner, JC Leroux
European Journal of Pharmaceutics and Biopharmaceutics 85 (1), 5-11, 2013
1032013
Combined approaches to the synthesis and study of glycoproteins
GJL Bernardes, B Castagner, PH Seeberger
ACS Chemical Biology 4 (9), 703-713, 2009
1022009
Automated solid‐phase synthesis of protected oligosaccharides containing β‐mannosidic linkages
JDC Codée, L Kröck, B Castagner, PH Seeberger
Chemistry–A European Journal 14 (13), 3987-3994, 2008
972008
Synthesis of a sialic acid α (2− 3) galactose building block and its use in a linear synthesis of sialyl Lewis X
S Hanashima, B Castagner, D Esposito, T Nokami, PH Seeberger
Organic letters 9 (9), 1777-1779, 2007
822007
Targeting bacterial toxins
ME Ivarsson, JC Leroux, B Castagner
Angewandte Chemie International Edition 51 (17), 4024-4045, 2012
762012
siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelators
EV Giger, B Castagner, J Räikkönen, J Mönkkönen, JC Leroux
Advanced healthcare materials 2 (1), 134-144, 2013
742013
Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis
B Zhu, S Trikudanathan, AL Zozulya, C Sandoval-Garcia, JK Kennedy, ...
Clinical immunology 142 (3), 351-361, 2012
732012
siRNA nanocarriers based on methacrylic acid copolymers
AE Felber, B Castagner, M Elsabahy, GF Deleavey, MJ Damha, ...
Journal of Controlled Release 152 (1), 159-167, 2011
722011
Modular design of redox-responsive stabilizers for nanocrystals
K Fuhrmann, A Połomska, C Aeberli, B Castagner, MA Gauthier, ...
ACS nano 7 (9), 8243-8250, 2013
612013
Reduction of olefins on solid support using diimide
P Lacombe, B Castagner, Y Gareau, R Ruel
Tetrahedron letters 39 (38), 6785-6786, 1998
491998
Characterization of calcium phosphate nanoparticles based on a PEGylated chelator for gene delivery
X Huang, D Andina, J Ge, A Labarre, JC Leroux, B Castagner
ACS applied materials & interfaces 9 (12), 10435-10445, 2017
472017
Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers
AE Schantl, A Verhulst, E Neven, GJ Behets, PC D’Haese, M Maillard, ...
Nature communications 11 (1), 721, 2020
462020
系统目前无法执行此操作,请稍后再试。
文章 1–20